A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
Vous n'êtes pas connecté
Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects of the opioid crisis.
A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
When Sheldon Houtman broke his arm 17 years ago, he left the hospital with a three-month supply of Percocet. “You don’t need that much. No, your...
March 5, 2025 -- A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and...
Scientists from Washington University School of Medicine in St. Louis and Stanford University have developed a synthetic compound that mimics the...
Diabetes and obesity are growing health concerns worldwide. A type of medication called GLP-1 receptor agonists, commonly used to treat type 2...
It has been five years since the World Health Organization (WHO) declared COVID-19 a pandemic in March 2020, a decision that would alter the...
by Shaun TandonDonald Trump's aid freeze was announced as a review that would last 90 days. Instead, the US president has unleashed sweeping cuts that...
The South East Health Unit (SEHU) Board of Health has approved the first budget for the newly-amalgamated agency. On Wednesday, the SEHU Board of...
The opioid epidemic has claimed more than half a million lives in the U.S. since 1999, about three-quarters of them men, according to the National...